Not applicableLooking for participantsNCT07474103
What this trial is testing
SCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC
Who this might be right for
Rectal Cancer, Adenocarcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 49